0.7963
price up icon4.16%   0.0318
after-market Handel nachbörslich: .80 0.0037 +0.46%
loading

Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten

pulisher
Mar 24, 2026

If You Invested $1,000 in Heron Therapeutics Inc (HRTX) - Stock Titan

Mar 24, 2026
pulisher
Mar 17, 2026

HRTX Stock Price, Quote & Chart | HERON THERAPEUTICS INC (NASDAQ:HRTX) - ChartMill

Mar 17, 2026
pulisher
Mar 16, 2026

Market Trends: Is Heron Therapeutics Inc stock technically oversold2026 Key Highlights & Daily Momentum Trading Reports - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 15, 2026

Clearline Capital LP Increases Holdings in Heron Therapeutics, Inc. $HRTX - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

Baker BROS. Advisors LP Purchases New Position in Heron Therapeutics, Inc. $HRTX - MarketBeat

Mar 15, 2026
pulisher
Mar 09, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Given Average Recommendation of "Hold" by Brokerages - MarketBeat

Mar 09, 2026
pulisher
Mar 08, 2026

HRTX SEC FilingsHeron Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 08, 2026
pulisher
Mar 06, 2026

Citigroup Inc. Increases Stock Position in Heron Therapeutics, Inc. $HRTX - MarketBeat

Mar 06, 2026
pulisher
Mar 05, 2026

Heron Therapeutics Signals Profitable Growth After Strong Quarter - TipRanks

Mar 05, 2026
pulisher
Mar 05, 2026

Earnings Call Summary | Heron Therapeutics(HRTX.US) Q4 2025 Earnings Conference - 富途牛牛

Mar 05, 2026
pulisher
Mar 02, 2026

HC Wainwright Has Negative Forecast for HRTX FY2026 Earnings - MarketBeat

Mar 02, 2026
pulisher
Mar 02, 2026

What is Northland Securities' Forecast for HRTX Q1 Earnings? - MarketBeat

Mar 02, 2026
pulisher
Feb 28, 2026

Heron Therapeutics (NASDAQ:HRTX) Rating Lowered to Strong Sell at Zacks Research - MarketBeat

Feb 28, 2026
pulisher
Feb 28, 2026

HRTX Should I Buy - Intellectia AI

Feb 28, 2026
pulisher
Feb 27, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 27, 2026
pulisher
Feb 27, 2026

What is HC Wainwright's Estimate for HRTX Q1 Earnings? - MarketBeat

Feb 27, 2026
pulisher
Feb 26, 2026

HRTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics (NASDAQ:HRTX) Issues Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Heron (HRTX) Q4 2025 Earnings Call Transcript - AOL.com

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics: Profitable Growth Outlook and Acute Care Momentum Underpin Buy Rating and $3 Target - TipRanks

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics outlines $173M–$183M 2026 sales targets amid acute care momentum and expanded commercial investment - MSN

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics Q4 Earnings Call Highlights - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:HRTX) 2026-02-26 - Seeking Alpha

Feb 26, 2026
pulisher
Feb 26, 2026

Key facts: Heron Therapeutics projects $173-$183M revenue by 2026; ZYNRELEF adoption rises; credit facilities expanded - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics (HRTX) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics, Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Earnings call transcript: Heron Therapeutics Q4 2025 reports strong growth By Investing.com - Investing.com Canada

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics Inc reports results for the quarter ended September 30Earnings Summary - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

HRTX: 2025 net revenue rose 7.4% to $154.9M, with strong Acute Care growth and positive EBITDA - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

HERON THERAPEUTICS ($HRTX) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics: Q4 Earnings Snapshot - Citizen Tribune

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics: Fourth Quarter Earnings Overview - Bitget

Feb 26, 2026
pulisher
Feb 26, 2026

HERON THERAPEUTICS, INC. /DE/ SEC 10-K Report - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics Q4 revenue dips as Acute Care segment holds fort - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results - The Manila Times

Feb 26, 2026
pulisher
Feb 26, 2026

HRTX: 2025 net revenue rose 7.4% to $154.9M, driven by Acute Care growth and new CMS J-Codes - TradingView

Feb 26, 2026
pulisher
Feb 24, 2026

Aug Sectors: Whats Heron Therapeutics Incs historical returnWeekly Profit Recap & Technical Pattern Based Signals - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 24, 2026

Heron Therapeutics Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView

Feb 24, 2026
pulisher
Feb 20, 2026

Heron Therapeutics, Inc. (HRTX) Stock Analysis: Exploring A Potential Upside Of 258.13% - DirectorsTalk Interviews

Feb 20, 2026
pulisher
Feb 19, 2026

Heron Therapeutics, Inc. $HRTX Shares Acquired by JW Asset Management LLC - MarketBeat

Feb 19, 2026
pulisher
Feb 19, 2026

Heron Therapeutics (HRTX) Expected to Announce Earnings on Thursday - MarketBeat

Feb 19, 2026
pulisher
Feb 18, 2026

Aug EndMonth: What are JOFF Fintech Acquisition Corp Debt Equity Composite Unitss growth leversMarket Trend Report & Verified Entry Point Detection - baoquankhu1.vn

Feb 18, 2026
pulisher
Feb 18, 2026

MSN Money - MSN

Feb 18, 2026
pulisher
Feb 18, 2026

Heron: Near The Bottom Of A Trading Range Despite Positives (NASDAQ:HRTX) - Seeking Alpha

Feb 18, 2026
pulisher
Feb 17, 2026

Clearline Capital reports 6.7% Heron Therapeutics stake (HRTX) - Stock Titan

Feb 17, 2026
pulisher
Feb 17, 2026

Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026 - The Manila Times

Feb 17, 2026
pulisher
Feb 17, 2026

Heron Therapeutics sets Feb. 26 webcast on 2025 results, business updates - Stock Titan

Feb 17, 2026
pulisher
Feb 14, 2026

Should I set a stop loss on Heron Therapeutics Inc.Dollar Strength & Entry Point Confirmation Signals - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Can Heron Therapeutics Inc. expand into new marketsWeekly Risk Report & Breakout Confirmation Trade Signals - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

How does Heron Therapeutics Inc. compare to its peersJuly 2025 Weekly Recap & Community Consensus Trade Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

How strong is Heron Therapeutics Inc. (AXD2) stock earnings growthJuly 2025 WrapUp & Safe Capital Growth Tips - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

How resilient is Heron Therapeutics Inc. stock in market downturnsJuly 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Heron Therapeutics, Inc. (NASDAQ:HRTX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Feb 12, 2026
$27.36
price up icon 1.82%
$47.03
price up icon 3.20%
$53.54
price up icon 4.29%
$88.77
price up icon 2.26%
ONC ONC
$283.45
price up icon 2.81%
$148.31
price up icon 6.59%
Kapitalisierung:     |  Volumen (24h):